2019 International Congress Archives - Page 42 of 217

Natural History of Movement Abnormalities on Hereditary Spastic Paraplegia: validation of timed functional instruments

J. Saute, G. Machado, AP. Zanardi, V. Martins, D. Burguêz, L. Jacinto-Scudeiro, E. Monteiro, L. Peyré-Tartaruga (Porto Alegre, Brazil)
NBIA-like MRI findings in a patient with Huntington’s disease

T. Shimizu, T. Matsukawa, Y. Abe, H. Suga, N. Tominaga, M. Nagai, T. Iizuka, H. Ishiura, J. Mitsui, S. Tsuji, R. Hanajima, K. Nishiyama (Yonago, Japan)
Need of next generation sequencing technology to de-convolute autosomal recessive cerebellar ataxias in India

S. Shakya, R. Kumari, A. Garg, A. Srivastava, M. Faruq (New Delhi, India)
Negative and Positive Feedback Processing in Parkinson’s Disease and Impulse Control Disorder: an ERP Study

A. Martini, R. Schifano, L. Weis, R. Biundo, S. Tamburin, J. Brooks, A. Antonini, G. Leoni, N. Edelstyn (Newcastle-Under-Lyme, United Kingdom)
Network localization of cervical dystonia based on causal brain lesions

J. Joutsa, D. Corp, R. Darby, C. Delnooz, B. Vande Warrenburg, D. Cooke, C. Prudente, J. Ren, M. Reich, A. Batla, K. Bhatia, H. Jinnah, H. Liu, M. Fox (Boston, MA, USA)
Neural correlates of compensatory process and impaired working memory in Parkinson’s disease during disease progression

T. Hattori, R. Reynolds, S. Horovitz, G. Chen, C. Lungu, E. Wassermann, M. Hallett (Tokyo, Japan)
Neural correlates of Level-1 and Level-2 diagnostic criteria for Mild Cognitive Impairment in Parkinson´s disease.

I. Aracil-Bolaños, F. Sampedro, J. Marín-Lahoz, A. Horta-Barba, S. Martínez-Horta, JM. González-de-Echávarri, J. Pérez-Pérez, H. Bejr-Kasem, B. Pascual-Sedano, MA. Boti, A. Campolongo, C. Izquierdo, A. Gironell, B. Gómez-Ansón, J. Pagonabarraga, J. Kulisevksy (Barcelona, Spain)
Neural correlates of visual cues for gait impairment in Parkinson’s disease: a preliminary analysis

S. Stuart, J. Wagner, S. Makeig, M. Mancini (Portland, OR, USA)
Neural plasticity based on the change of the glutamate receptors: Repetition of electrical stimulation for the reduction of Parkinsonian symptoms

GT. Kim, N. Nguyen, KS. Kim (Incheon, Republic of Korea)
Neuritic pathology in Parkinson’s Disease results from loss of anti-oxidant response activity

S. Ryan, M. Stykel, C. Coackley, T. Ryan (Guelph, ON, Canada)
Neuroanatomical and clinical predictors of pain in patients with early de novo Parkinson’s disease

. Cousins, H. Wilson, T. Yousaf, S. Caminiti, M. Politis (London, United Kingdom)
Neuroanatomical and Electrocortical Networks correlates in Parkinson’s Disease Patients with Mild Cognitive Impairment:The PaCoS Study

G. Donzuso, G. Giuliano, R. Monastero, R. Baschi, G. Mostile, A. Luca, C. Cicero, M. Zappia, A. Nicoletti (Catania, Italy)
Neuroanatomical correlates of early cognitive change in Parkinson’s disease

E. Bunting, L-A. Leyland, R. Weil (London, United Kingdom)
Neuroart: A Hummingbird in the Cage of the Brain

A. Kleinert (Tuxtla Gutierrez, Mexico)
Neurocognitive changes after STN-DBS among PD patients – a 2-year follow-up study in Hong Kong

V. Tang, D. Chan, XL. Zhu, D. Chan, C. Lau, A. Chan, K. Ma, J. Yeung, V. Mok, W. Poon (N.t., Hong Kong)
Neurocognitive changes post-bilateral globus pallidus interna DBS for Parkinson’s disease with autologous sural nerve graft to the substantia nigra or nucleus basalis of Meynert

L. Koehl, E. Wallace, J. Quintero, F. Schmitt, C. van Horne (Lexington, KY, USA)
Neurofascin is a novel gene associated with autosomal recessive spastic and polyneuropathy

L. Straniero, E. Monfrini, S. Bonato, G. Monzio Compagnoni, A. Bordoni, R. Dilena, R. Silipigni, D. Ronchi, S. Duga, A. Di Fonzo (Pieve Emanuele, Milan, Italy)
Neurofeedback-guided motor imagery in Parkinson’s disease

S. Tinaz, M. Elfil, J. Lemere, S. Basu, R. Sinha, D. Scheinost, M. Hampson (New Haven, CT, USA)
Neuroimaging in Parkinson’s disease dementia: Connecting the dots

R. Weil, J. Hsu, R. Darby, L. Soussand, M. Fox (Nashville, TN, USA)
Neuroinflammation and activation of Zif-268 in dyskinetic 6-OHDA-lesioned rats is counteracted by association of a 5-HT1A/1B receptor agonist and an A2A receptor antagonist

A. Pinna, G. Costa, M. Serra, M. Morelli (Monserrato, Italy)
Neurological complications secondary to metronidazole: Case Report

M. Teran, P. Salles (Santiago, Chile)
Neurological Wilson Disease: Clinical Aspects and Evolution in 10 Cases

Y. Mecheri, F. Serradj, A. Boulefkhad, H. Semra, A. Mzahem, A. Hamri, Y. Sifi (Constantine, Algeria)
Neurology Residents Versus a Mobile Medical Application in deducing differential diagnoses in Movement Disorders: A multi-center, cross-sectional, observational study

V. Vishnu, P. Vinny, R. Rajan, V. Goyal, P. Srivastava, V. Lal, P. Sylaja, L. Narasimhan, S. Dwivedi, P. Nair, D. Ramachandran, A. Gupta (New Delhi, India)
Neuromelamin-MRI in patients with Pure Autonomic Failure

O. Roman, P. Trujillo-Diaz, K. Hay, I. Biaggioni, C. Shibao, D. Claassen (Nashville, TN, USA)
Neuromelanin MRI detects monoaminergic cell loss in Huntington Disease Expansion Gene Carriers.

ER. de Natale, H. Wilson, G. Dervenoulas, F. Niccolini, SJ. Tabrizi, M. Politis (London, United Kingdom)
Neuromodulatory potentials of revasterol and Carpogon capitatus Roxb on the rat brain: Novel approach for Parkinson’s diseases

DS. Singh, MS. Singh, PK. Kumar, YK. Gupta (Allahabad, India)
Neuromuscular electrical stimulation for the treatment of jaw-closing dystonia

C. Miller-Patterson, E. Burton (Pittsburgh, PA, USA)
NEURONAL NETWORK UNDERLYING DYSPHAGIA IN PARKINSON’S DISEASE

S. Polychronis, G. Pagano, VC. Suarez Contreras, T. Yousaf, M. Politis (London, United Kingdom)
Neuronal Network Underlying Speech Difficulties in Parkinson’s Disease

S. Polychronis, G. Pagano, VC. Suarez Contreras, T. Yousaf, M. Politis (London, United Kingdom)
Neuropathological findings in a SPG4 gene mutation carrier

S. Forcén, I. Aldecoa, AM. Crespo, O. Ramos, L. Ispierto, R. álvarez, D. Vilas (Badalona, Spain)
Neuropathology in a case of HD-like syndrome caused by mutations in RNF216

P. Santens, A. Sieben, B. Dermaut (Ghent, Belgium)
Neuropathy in patients treated with LCIG in the Czech and the Slovak Republic

P. Havránková, J. Klempíř, J. Roth, E. Růžička, M. Baláž, M. Bareš, I. Rektorová, M. Kaiserová, P. Kaňovský, M. Minár, K. Gmitterová, P. Valkovič, M. škorvánek, V. Haň, L. Skička, J. Necpál, M. Grófik, E. Kurča, R. Jech (Praha, Czech Republic)
Neurophysiologic characterization of Re-emergent tremor (RET) in Parkinson’s disease

G. Leodori, D. Belvisi, A. Fabbrini, M. de Bartolo, M. Costanzo, F. Undurraga, A. Conte, A. Berardelli (Bethesda, MD, USA)
Neuroprotective actions of red propolis extract and formononetin in a rat model of Parkinson’s disease

M. Gomes, S. Barroso, J. de Oliveira, D. Marques, A. Santos, J. Cardoso (Aracaju, Brazil)
Neuroprotective and neurotrophic efficacy of Ginkgo biloba extracts against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington’s disease

P. Kashyap, S. Gupta (Darbhanga, India)
Neuroprotective effect of crocus sativus in lead-induced dopaminergic neurotoxicity in Meriones shawi: A possible link with Parkinson’s disease

L. Tamegart, A. Abbaoui, R. Makbal, M. Zroudi, M. Bouyatas, B. Bouizgarne, H. Gamrani (Marrakesh, Morocco)
Neuroprotective effect of Lemon oil on 6-OHDA-Induced Apoptosis in PC12 Cells through the ROS-NO Pathway

V. Kumar (Allahabad, India)
Neuroprotective effect of Yerba mate (Ilex paraguariensis) in a Drosophila model of Parkinson ’s disease

P. Ballestero, A. Bernardi, H. Hauche Pedernera, O. Gershanik, N. Muraro, J. Ferrario (Capital Federal, Argentina)
Neuroprotective Effects of Combined Administration of Coenzyme Q10 and Vitamin-E in Chronic Cerebral Hypoperfusion-Induced Neurodegeneration in Rats

WMY. Mohamed, MA. Alazimi (Kuantan, Malaysia)
Neuropsychiatric clusters in patients with Parkinson’s disease and their clinical and demographic correlates

M. Sommerauer, C. Schedlich-Teufer, P. Reker, E. Kalbe, J. Kessler, M. Barbe (Köln, Germany)
Neuropsychiatric manifestations in Parkinson’s disease

O. Cherkaoui Rhazouani, N. Jalami, M. Chraa, N. Kissani (Marrakech, Morocco)
NEUROPSYCHIATRIC SYMPTOMS IN EARLY TO ADVANCED PATIENTS WITH THE RICHARDSON’S SYNDROME VARIANT OF PROGRESIVE SUPRANUCLEAR PALSY

A. Horta-Barba, J. Pagonabarraga, S. Martinez-Horta, B. Pascual-Sedano, J. Marin-Lahoz, J. Perez-Perez, I. Aracil-Bolanos, H. Bejr-Kasem, A. Campolongo, C. Izquierdo, F. Sampedro, J. Kulisevsky (Barcelona, Spain)
Neuropsychological and behavioral profile of patients with isolated REM sleep behaviour disorders (iRBD) and patients with RBD associated with Parkinson’s Disease (PDRBD)

M. Figorilli, P. Pisanu, MG. Mascia, M. Meloni, RM. Lecca, G. Gioi, P. Congiu, L. Tamburrino, G. Defazio, M. Fantini, M. Puligheddu (Monserrato, Italy)
Neuropsychological changes over the first 6 years of Parkinson’s disease in the ICICLE-PD cohort

R. Lawson, G. Duncan, T. Khoo, D. Breen, M. Camacho, C. Williams-Gray, R. Barker, L. Rochester, D. Burn, A. Yarnall (Newcastle Upon Tyne, United Kingdom)
Neuropsychological differences between patients with Parkinson’s Disease and Essential Tremor

M. Zorn, K. Duff, J. Rolston, C. Aquino, J. Ballard, P. Moretti (Salt Lake City, UT, USA)
Neuropsychological profile of patients with functional movement disorders

G. Vechetova, T. Nikolai, M. Slovak, Z. Hanzlikova, M. Vranka, E. Bolcekova, T. Teodoro, E. Ruzicka, M. Edwards, T. Serranova (Prague, Czech Republic)
Neuroradiological differences between patients with akinesia-dominant and tremor-dominant Parkinson’s disease

KO. Ohta, TN. Nakajima (Kashiwazaki, Japan)
New epidemiological data of Parkinson’s Disease in Ukraine

Y. Trufanov, N. Svyrydova, A. Galusha, V. Svistun, I. Harkava, H. Bondarenko, N. Zhhilova (Kyiv, Ukraine)
New Neuropathological Staging System for Lewy Body Disease

J. Toledo, L. Walker, J. Trojanowski, I. Mckeith, J. Attems (Houston, TX, USA)
Nigral Iron Load as Diagnostic Parameter in Parkinson’s Disease

S. Franthal, L. Pirpamer, N. Homayoon, M. Koegl, P. Katschnig-Winter, K. Wenzel, C. Langkammer, S. Ropele, F. Fazekas, R. Schmidt, P. Schwingenschuh (Graz, Austria)
Nigrostriatal degeneration in DYT-PRKRA: new insights on a rare disorder

MJ. Pinto, J. Massano, MJ. Rosas, A. Oliveira (Porto, Portugal)
NILO-PD: A Phase 2A Study of Nilotinib in Patients with Advanced Parkinson’s Disease: Study Design and Status Update

T. Simuni, B. Fiske, K. Merchant, C. Coffey, H. Matthews, R. Wyse, P. Brundin, D. Simon, M. Schwarzschild, D. Weiner, J. Adams, C. Venuto, L. Trusso, L. Baker, M. Kostrzebski, T. Ward, G. Rafaloff (Boston, MA, USA)
NKX2-1-Related Disorder with Cerebral Folate Deficiency

J. Maclean, Q. Luc, L. Ramos-Platt, S. Saitta, C. Quindipan (Los Angeles, CA, USA)
No difference in balance and gait parameters of the patients with akinetic-rigid and tremor-dominant Parkinson’s disease

AC. Kalkan, T. Kahraman, BO. Ugut, B. Donmez Colakoglu, A. Genc (Izmir, Turkey)
No evidence for early emotional processing in the subthalamic nucleus – a single neuron study

T. Sieger, T. Serranová, F. Růžička, D. Urgošík, R. Jech (Prague, Czech Republic)
No link between striatal dopaminergic axons and dopamine transporter imaging in Parkinson’s disease

E. Honkanen, L. Saari, K. Orte, M. Gardberg, T. Noponen, J. Joutsa, V. Kaasinen (Turku, Finland)
Nocturnal stridor in multiple system atrophy: video-polysomnography and clinical features

H. Ryu, J. Paek, S. You, M. Kim, Y. Kim, J. Kim, K. Kim, S. Lee, S. Chung (Daegu, Republic of Korea)
Non motor fluctuations in Parkinson’s disease: Findings from a Tunisian cohort

M. Ben Djebara, K. Laabidi, A. Nasri, A. Rekik, S. Mrabet, A. Gargouri, I. Kacem, R. Gouider (Tunis, Tunisia)
Non motor symptoms Parkinson’s disease

N. Bagdanova, Z. Zuleiha (Kazan, Russian Federation)
Non-CpG methylation in the FXN gene in patients with Friedreich’s ataxia

E. Nuzhnyi, N. Abramycheva, M. Ershova, S. Klyushnikov, N. Nikolaeva, S. Illarioshkin, E. Fedotova (Moscow, Russian Federation)
Non-Invasive Vagus Nerve Stimulation: A non-pharmacological approach to target gait impairment in Parkinson’s disease?

A. Yarnall, R. Morris, H. Hunter, JP. Taylor, M. Baker, L. Rochester (Newcastle Upon Tyne, United Kingdom)
Non-Medical Switching: Impact on Movement Disorders Patients’ Access and Care

B. Kennedy, J. Peterson, D. Charles (Washington, DC, USA)
Non-motor symptoms and risk of functional dependency in early Parkinson’s disease

R. Kim, D. Yoo, JH. Im, HJ. Kim, B. Jeon (Seoul, Republic of Korea)
Non-motor symptoms burden grading in Parkinson disease with the Movement Disorders Society – Non-Motor Rating Scale (MDS-NMS)

D. Weintraub, C. Rodriguez-Blazquez, A. Schrag, A. Rizos, KR. Chaudhuri, P. Martinez-Martin (Madrid, Spain)
Non-motor symptoms burden is greater in early Parkinson’s disease patients with motor complications

D. Santos, T. de Deus, E. Suárez Castro, A. Aneiros, S. Jesús, M. Aguilar, LL. Planellas, J. García Caldentey, N. Caballol, B. Vives, J. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, MA. Avila, MJ. Catalán, L. López Díaz, JM. García Moreno, B. Solano, M. álvarez Sauco, L. Vela, S. Escalante, E. Cubo, F. Carrillo, JC. Martínez Castrillo, P. Sánchez Alonso, MG. Alonso Losada, N. López Ariztegui, P. Martínez Martín, SG. Coppadis (A Coruña, Spain)
Non-motor symptoms contribute to the caregiver burden in Progressive Supranuclear Palsy

ZC. Chen, YM. Liu (Jinan, China)
Non-motor Symptoms in Hyperkinetic Movement Disorders

H. Egit, M. Balal, M. Demirkiran (Adana, Turkey)
Non-motor symptoms in Myoclonus-Dystonia: a comparison to other dystonia subtypes

E. Timmers, M. Smit, A. Kuiper, A. Bartels, S. Vander Veen, A. Vander Stouwe, P. Santens, B. Bergmans, M. Tijssen (Groningen, Netherlands)
Non-motor symptoms in Parkinson disease motor subtypes: a study using the new MDS-NMS

P. Martinez-Martin, C. Rodriguez-Blazquez, A. Schrag, D. Weintraub, A. Rizos, KR. Chaudhuri (Madrid, Spain)
Non-Motor Symptoms in Patients with Parkinson’s Disease: Effect of Gender, Disease Severity, and Disease Phenotype

V. Holla, A. Lenka, S. Chaithra, A. Stezin, S. Prasad, N. Kamble, R. Yadav, P. Pal (Bengaluru, India)
Nonmotor Symptoms in Parkinson’s Disease: 36-month Follow-up Study Comparing Bilateral Subthalamic Stimulation and Standard-of-care Medication

S. Jost, A. Sauerbier, K. Ray-Chaudhuri, V. Visser-Vandewalle, K. Ashkan, M. Silverdale, J. Evans, A. Rizos, A. Schnitzler, P. Löhrer, JN. Petry-Schmelzer, M. Barbe, A. Antonini, P. Martinez-Martin, G. Fink, L. Timmermann, H. Dafsari (Cologne, Germany)
Normative Curves for Selected Unified Huntington Disease Rating Scale Measures

J. Mills, J. Long, A. Mohan, J. Ware, C. Sampaio (Iowa City, IA, USA)
Normative Reference for Timed Up and Go Test (TUG) in Young Indian Adults- Preliminary Results

D. Kaur, K. Umakant, T. Aziz, P. Jaiswal, M. Kumari, A. Gupta, G. Kumar (Patna, India)
Novel compound heterozygous mutations in the TSFM gene causes childhood-onset chorea

CH. van Riesen, K. von Au, S. Biskup, A. Kühn, A. Kaindl, A. van Riesen (Berlin, Germany)
Novel exploratory outcome assessments in GENERATION HD1

D. Trundell, S. Schobel, R. Roos, K. Anderson, A. Thobhani, G. Hooper, M. Nguyen, S. Tabrizi (Welwyn Garden City, United Kingdom)
Novel familial HPCA mutation associated with autosomal recessive dystonia: Strengthening the role of HPCA in hereditary movement disorders.

S. Siegert, W. Schmidt, R. Bittner, S. Gobara, M. Freilinger (Vienna, Austria)
Novel Mutation of NUS1 Gene Presenting With Developmental And Epileptic Encephalopathy and Movement Disorders

N. Prakash, N. Mencacci, C. Zadikoff, L. Kinsley, T. Simuni, S. Lubbe, D. Krainc (Chicago, IL, USA)
Novel p.Pro193Arg missense mutation in ABCD1-gene associated with phenotype of ALD/AMN: a case report

K. Steidel, J. Waldthaler, C. Eggers, D. Pedrosa (Marburg, Germany)
Nrf2 pathway in patients with Parkinson’s disease

T. Schirinzi, S. Petrillo, G. Di Lazzaro, N. Mercuri, E. Bertini, F. Piemonte, A. Pisani (Rome, Italy)
NS-PARK cohort: a nationwide real life longitudinal cohort of PD patients

H. Alfaisal, F. Durif, S. Thobois, L. Defebvre, JP. Azulay, P. Couratier, P. Damier, D. Devos, S. Drapier, A. Doe Demaindreville, S. Frismand, C. Geny, C. Giordana, JL. Houeto, P. Krystkowiak, E. Magnin, D. Maltête, W. Meissner, C. Moreau, E. Moro, P. Remy, C. Thiriez, C. Tranchant, F. Viallet, M. Vidailhet, E. Dellapina, V. Chaigneau, C. Dongmo, F. Tubach, Y. de Rycke, O. Rascol, JC. Corvol (Paris, France)
Number of people with Parkinson’s dementia in New Zealand

T. Pitcher, D. Myall, J. Dalrymple-Alford, M. Macaskill, T. Anderson (Christchurch, New Zealand)
Nutritional status in patients with Parkinson’s disease and its relationship with the motor phenotype.

R. Cruz, J. Balderas, C. Navarro, L. Zuazua, M. Rodriguez, A. Cervantes (Mexico City, Mexico)